Amabili Giulio, Maranesi Elvira, Barbarossa Federico, Margaritini Arianna, Bonfigli Anna Rita, Su Fong-Chin, Lin Chien-Ju, Chieh Hsiao-Feng, Vasseur Dianne, Nap Henk Herman, Hsu Yeh-Liang, Bai Dorothy, Bevilacqua Roberta
Scientific Direction, IRCCS INRCA, Ancona, Italy.
Medical Device Innovation Center (MDIC), National Cheng Kung University, Tainan City, Taiwan.
JMIR Res Protoc. 2025 Aug 6;14:e59860. doi: 10.2196/59860.
Dementia is a syndrome characterized by a wide spectrum of symptoms and needs. There is no cure for this syndrome, which represents a major challenge to society in terms of quality of life for those affected and in terms of workload and stress burden for those who take care of them.
The Healthy Ageing Ecosystem for People With Dementia (HAAL) aimed to improve the quality of life of both people with dementia and their formal caregivers (FCs) and informal caregivers (ICs) by providing a personalized set of devices to the person with dementia, along with a dashboard designed for caregivers to monitor and manage the older person.
The HAAL platform comprises a dashboard that integrates, aggregates, and analyzes heterogeneous data gathered from an ecosystem of devices designed for and tested with people with dementia. The study was designed as a technical feasibility pilot to test the HAAL ecosystem in 3 countries: Italy, Taiwan, and the Netherlands, where older people with initial, moderate, and severe dementia were enrolled, respectively. The study was run in 2 stages: the alpha and beta pilot studies aimed to test the second and third prototypes of the platform, respectively.
The alpha test was conducted from March to May 2023, involving 41 end users, of which 13 were people with dementia, 13 were ICs, and 15 were FCs. The beta test was conducted from September 2023 to February 2024, involving 83 end users, of which 26 were people with dementia, 20 were ICs, and 37 were FCs. The results have been elaborated and are supposed to be published by 2026.
The HAAL pilot study was an innovative feasibility study whose primary objectives were to assess reduction in care load for FCs, stress relief for FCs and ICs, and improvement in the perceived quality of life for ICs and people with dementia. The study also evaluated the usability and the acceptance of the platform. Preliminary analyses of the results showed that the HAAL platform partially relieved caregivers' stress and that the quality of life of people with dementia did not worsen over the test period.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/59860.
痴呆症是一种具有广泛症状和需求的综合征。这种综合征无法治愈,对社会来说,这在受影响者的生活质量方面,以及在照顾他们的人的工作量和压力负担方面,都是一项重大挑战。
痴呆症患者健康老龄化生态系统(HAAL)旨在通过为痴呆症患者提供一套个性化设备,以及为照顾者设计的用于监测和管理老年人的仪表板,来提高痴呆症患者及其正式照顾者(FC)和非正式照顾者(IC)的生活质量。
HAAL平台包括一个仪表板,该仪表板整合、汇总和分析从为痴呆症患者设计并经过测试的设备生态系统中收集的异构数据。该研究被设计为一项技术可行性试点研究,在3个国家(意大利、台湾和荷兰)测试HAAL生态系统,分别招募了患有初期、中度和重度痴呆症的老年人。该研究分两个阶段进行:alpha和beta试点研究分别旨在测试平台的第二个和第三个原型。
alpha测试于2023年3月至5月进行,涉及41名最终用户,其中13名是痴呆症患者,13名是IC,15名是FC。beta测试于2023年9月至2024年2月进行,涉及83名最终用户,其中26名是痴呆症患者,20名是IC,37名是FC。结果已得到详细阐述,预计将于2026年发表。
HAAL试点研究是一项创新性可行性研究,其主要目标是评估FC的护理负担减轻情况、FC和IC的压力缓解情况,以及IC和痴呆症患者的生活质量感知改善情况。该研究还评估了平台的可用性和可接受性。对结果的初步分析表明,HAAL平台部分缓解了照顾者的压力,并且在测试期间痴呆症患者的生活质量没有恶化。
国际注册报告标识符(IRRID):RR1-10.2196/59860